Re: Farmas USA
TEVA
US lawmakers push Mylan, Teva over drug pricing probe: statement
The head of the U.S. House of Representative's oversight panel on Wednesday called on three drugmakers to turn over documents as part of an ongoing congressional review over generic drug price increases and accused the companies of "apparent efforts to stonewall" the probe.
«Después de nada, o después de todo/ supe que todo no era más que nada.»